Latent inhibition deficits in high-schizotypal normals: Symptom-specific or anxiety-related?

Schizophrenia Research

Volumn 53, Issue 1-2, 2002, Pages 109-121

  Braunstein Bercovitz, H ^a   Rammsayer, T ^b   Gibbons, H ^b   Lubow, R E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Anxiety; Attention; Latent inhibition; Schizophrenia; Schizotypal

Indexed keywords

ANXIETY; ATTENTION; HUMAN; LATENT INHIBITION; MENTAL DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL THEORY; REVIEW; SCHIZOPHRENIA; STIMULUS RESPONSE; SYMPTOM; TASK PERFORMANCE;

EID: 0036132678     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00166-9     Document Type: Review

References (153)

1. Reverse Stroop effect in the performance of schizophrenics
2. Effects of tobacco smoking, schizotyphy and number of preexposures on latent inhibition in healthy subjects
3. The disorder of consciousness in schizophrenia
4. Anxiolytic effects of dopamine receptor ligands: Involvement of dopamine autoreceptors
5. Differential performance of acute and chronic schizophrenics in a latent inhibition task
6. Latent inhibition and 'psychotic proneness' in normal subjects
7. Individual differences in negative priming: Relation with schizotypal personality traits
8. Evidence of reduced cognitive inhibition in schizophrenia
9. The multidimensional nature of schizotypal traits: A factor analytic study with normal subjects
10. Context, time and memory retrieval in the interference paradigm of Pavlovian conditioning
11. Information processing and attention dysfunctions in schizophrenia
12. Effect of antipsychotic medication on speed of information processing in schizophrenic patients
13. Is the attentional dysfunction in schizotypy a function of anxiety?
14. Are high schizotypal normals distractible or limited in attentional resources? A study of latent inhibition as a function of masking task load and schizotypy
15. Latent inhibition as a function of modulation of attention to the preexposed irrelevant stimulus
16. Stress and schizophrenia
17. Neuropsychological impairments in deficit versus nondeficit forms of schizophrenia
18. Neuropsychological assessment of schizophrenic patients during a psychotic episode: Persistent cognitive deficit?
19. Blink rate in childhood schizophrenia spectrum disorder
20. Cognitive processing of trauma cues in rape victims with post traumatic stress disorder
21. Scales for physical and social anhedonia
22. Body-image aberration in schizophrenia
23. Physical anhedonia, perceptual aberration, and psychosis proneness
24. Putatively psychosis-prone subjects 10 years later
25. Single indicator of risk for schizophrenia: Probable fact or likely myth?
26. Schizotypy and lateralised negative priming in schizophrenics' and neurotics' relatives
27. Schizotypy and hemisphere function - I: Theoretical considerations and the measurement of schizotypy
28. Performance on the emotional Stroop task in groups of anxious, expert, and control subjects: A comparison of computer and card presentation formats
29. Latent inhibition and recall of irrelevant stimuli in Type-A and Type-B subjects
30. Latent inhibition and recall/recognition of irrelevant stimuli as a function of preexposure duration in high and low psychotic-prone normal subjects
31. Effects of smoking status and schizotypy on latent inhibition
32. Magical ideation as an indicator of schizotypy
33. A further investigation of cognitive inhibition in obsessive-compulsive disorder and other anxiety disorders
34. Selective dopamine depletion with the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze
35. Schizothymia-cyclothymia as a dimension of personality. II. Experimental
36. The definition and measurement of Psychoticism
37. A revised version of the psychoticism scale
38. Cognitive functioning and anxiety
39. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats
40. From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia
41. Failure to inhibit irrelevant information in non-clinical schizotypal individuals
42. Information processing in obsessive-compulsive disorder
43. Attentional bias in anxiety: Selective or not?
44. Attentional bias in anxiety: A defective inhibition hypothesis
45. Negative priming from ignored distractors in visual selection: A review
46. Psychoneuroendocrine approaches to the study of emotion as related to stress and coping
47. D2-like dopamine receptor mediation of social-emotional reactivity in a mouse model of anxiety: Strain and experience effects
48. Prozeaeigenschaften latenter hemmung im paradigma 'visual search'
49. Persoenlichkeitsmerkmale und latente hemmung
50. The effects of preexposure to nonattended stimulus on subsequent learning: Latent inhibition in adults
51. Vulnerability to stress ulcerogenesis in rats differing in anxiety: A dopaminergic correlate
52. Integrating schizophrenia
53. The neuropsychology of schizophrenia
54. Abolition of latent inhibition in acute, but not chronic, schizophrenics
55. Abolition of latent inhibition by a single 5 mg dose of D-amphetamine in man
56. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: Implications for schizophrenia
57. Latent inhibition in drug-naive schizophrenics: Relationship to duration of illness and dopamine D2 binding using SPET
58. Interaction of tail-pressure stress and D-amphetamine in disruption of the rat's ability to ignore an irrelevant stimulus
59. The interaction between schizotypy and latent inhibition: Modulation by experimental parameters
60. Quality of life in schizophrenia: Contributions of anxiety and depression
61. The effect of stress on the suppression of erroneous competing responses
62. The structure of self-report schizotypy in twins
63. Effects of D-amphetamine and haloperidol on latent inhibition in healthy male volunteers
64. Blockade of latent inhibition following increase or decrease of GABA(A) transmission
65. The measurement of hallucinatory predisposition in male and female prisoners
66. Perceptual load as a major determinant of the locus of selection in visual attention
67. Selective processing of emotional information in obsessive compulsive disorder
68. Long-term effects of prenatal stress and postnatal maternal separation on emotionality and attentional processes
69. Latent inhibition in human Pavlovian differential conditioning: Effects of additional stimulation after preexposure and relation to schizotypal traits
70. Latent inhibition in humans: Single cue conditioning revisited
71. Psychosis proneness in a non-clinical sample II: A multi-experimental study of 'attentional malfunctioning'
72. Latent inhibition as a measure of learned inattention: Some problems and solutions
73. Latent inhibition in humans: Data, theory, and implications for schizophrenia
74. Visual search as a function of type of prior experience with target and distractor
75. Latent inhibition: The effect of non-reinforced pre-exposure to conditional stimulus
76. Conditioned attention theory
77. Latent inhibition and schizophrenia
78. Latent inhibition in low and high 'psychotic-prone' normal subjects
79. The effects of target and distractor familiarity on visual search in de novo Parkinson's disease patients: Latent inhibition and novel pop-out
80. Visual search in schizophrenia: Latent inhibition and novel pop-out effects
81. The effects of target and distractor familiarity on visual search in anxious children: Latent inhibition and novel pop-out
82. Performance on the visual search analog of latent inhibition is modulated by an interaction between schizotypy and gender
83. Lifetime prevalence of mood and anxiety disorders in twin pairs discordant for schizophrenia
84. Half a century research on the Stroop effect: An integrative review
85. Individual differences in the selective processing of threatening information, and emotional responses to a stressful life event
86. A theory of attention: Variations of the associability of stimuli with reinforcement
87. New scales for the assessment of schizotypy
88. Attentional bias in anxiety: Selective search or defective filtering
89. Determinants of negative priming
90. The growth hormone response to apomorphine at 4 days postpartum in women with history of major depression
91. Current methodology in research on the etiology of schizophrenia: Serious difficulties which suggest the use of the high-risk-group method
92. Schizotaxia, schizotypy, schizophrenia
93. Towards an integrated theory of schizotaxia, schizotypy, and schizophrenia
94. The comparator hypothesis: A response rule for the expression of associations
95. Social anhedonia in the prediction of psychosis proneness
96. Selective processing of threat cues in anxiety states: A replication
97. A follow-up study of cognitive bias in generalized anxiety disorder
98. Personality correlates of schizotypy factors
99. Further evidence of reduced negative priming in positive schizotypy
100. The pharmacology of latent inhibition as an animal model of schizophrenia
101. Personality dimensions, schizotypal and borderline personality traits and psychosis proneness
102. Dysphoric mood and symptomatology in schizophrenia
103. Aspects of dysphoria and symptoms of schizophrenia
104. Information processing and attentional functioning in the developmental course of schizophrenic disorder
105. A heuristic vulnerability/stress model of schizophrenic episodes
106. Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress
107. Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia
108. Brain mechanisms of social anxiety disorder
109. The effects of antipsychotic medication and diagnostic criteria on distractibility in schizophrenia
110. A model of Pavlovian learning: Variations in the effectiveness of conditioned but not unconditioned stimuli
111. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2)
112. The SPQ: A scale for the assessment of schizotypal personality based on DSM-III-R criteria
113. Behavioral functions of nucleus-accumbens dopamine - Empirical and conceptual problems with the anhedonia hypothesis
114. Normal sustained effects of selective attention are absent in schizophrenic patients withdrawn from medication
115. The effects of chronic corticosterone administration on amphetamine-induced activity, spatial learning and latent inhibition (LI)
116. Gender and age-dependent differences in latent inhibition following pre-weaning non-handling implications for a neurodevelopmental animal model of schizophrenia
117. Biologic factors in schizotypal personal disorders
118. Brain structure/function and the dopamine system in schizotypal personality disorder
119. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia
120. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics
121. Studies of interference in serial verbal reactions
122. Latent inhibition in schizophrenia
123. Visuospatial priming and latent inhibition in children and adults with Tourette's disorder
124. Enhanced visual latent inhibition in obsessive-compulsive disorder
125. The role of dopaminergic mechanisms on the brain in various models of anxious states
126. Effects of nicotine and amphetamine on latent inhibition in human subjects
127. Information processing in post traumatic stress disorder
128. The negative priming effect: Inhibitory priming by ignored objects
129. Limits in controlling the focus of attention
130. Responding to subliminal threat cues is related to trait anxiety and emotional vulnerability: A successful replication of MacLeod and Hagan (1992)
131. A scale for the measurement of schizotypy
132. Neuroleptic effects on neuropsychological test performance in schizophrenia
133. The multidimensionality of schizotypy
134. Priming in STM: An information processing mechanism for self-generated or retrieval-generated depression in performance
135. Neural substrates of latent inhibition: Switching model
136. Neural substrates of latent inhibition: An update
137. The effects of early handling on latent inhibition in male and female rats
138. Further evidence for a multidimensional personality disposition to schizophrenia in terms of cognitive inhibition
139. Cognitive inhibition and schizophrenic symptom subgroups
140. Anti-psychotic drug effects in a model of schizophrenic attentional disorder: A randomized control trial of the effects of haloperidol on latent inhibition in healthy subjects
141. Haloperidol enhances latent inhibition in visual tasks in healthy people
142. Reduced latent inhibition in people with schizophrenia: An effect of psychosis or of its treatment
143. Effects of conditioned fear stress on dopamine release in the rat frontal cortex
144. Context control of negative transfer induced by preexposure to irrelevant stimuli: Latent inhibition in humans